(Q56786810)
Statements
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response (English)
0 references
October 2006
0 references
176
0 references
4 Pt 1
0 references
1349-53; discussion 1353
0 references